Abstract
Purpose
To report the experience of a percutaneous closure device used for transfemoral transcatheter aortic valve implantation (TAVI) in an unselected patient and operator population.
Materials and Methods
Eighty-two consecutive patients (32 women, 50 men) who underwent transfemoral TAVI between September 2009 and February 2014 at our hospital were retrospectively reviewed for percutaneous closure device (PCD) failure, vascular complications, and bleeding. The diameter and calcification of the common femoral artery (CFA) and the thickness of the subcutaneous fat layer in the groin were assessed on computed tomography images.
Results
The incidences of PCD failure and minor and major vascular complications were 19.5 % (n = 16/82), 19.5 % (n = 16/82), and 7 % (n = 6/82) respectively. 8.5 % (n = 7/82) had a minor perioperative bleeding, 6 % (n = 5/82) had a major bleeding, and none had any life-threatening bleeding. When PCD failed, haemostasis was obtained with fascia suturing, covered stent placement, or with surgical cutdown. Thirty-day mortality and 1-year all-cause mortality were 8.5 % (n = 7/82) and 19.5 % (n = 16/82), respectively. In a multiple regression analysis, the CFA diameter and the presence of severe calcification were independently related to PCD failure (correlation coefficient = −0.24, p = 0.027 and correlation coefficient = 0.23, p = 0.036, respectively).
Conclusion
PCD failure was related to a small CFA diameter and to a severely calcified CFA. Failure could largely be managed with minimally invasive techniques such as covered stents or fascia suturing.
Similar content being viewed by others
References
Gilard M, Eltchaninoff H, Iung B, et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med. 2012;366(18):1705–15.
Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597–607.
Hayashida K, Lefevre T, Chevalier B, et al. Transfemoral aortic valve implantation new criteria to predict vascular complications. JACC Cardiovasc Interv. 2011;4(8):851–8.
Etezadi V, Katzen BT, Naiem A, et al. Percutaneous suture-mediated closure versus surgical arteriotomy in endovascular aortic aneurysm repair. J Vasc Interv Radiol. 2011;22(2):142–7.
Van Mieghem NM, Tchetche D, Chieffo A, et al. Incidence, predictors, and implications of access site complications with transfemoral transcatheter aortic valve implantation. Am J Cardiol. 2012;110(9):1361–7.
Hayashida K, Lefevre T, Chevalier B, et al. True percutaneous approach for transfemoral aortic valve implantation using the Prostar XL device: impact of learning curve on vascular complications. JACC Cardiovasc Interv. 2012;5(2):207–14.
Genereux P, Webb JG, Svensson LG, et al. Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. J Am Coll Cardiol. 2012;60(12):1043–52.
Toggweiler S, Gurvitch R, Leipsic J, et al. Percutaneous aortic valve replacement: vascular outcomes with a fully percutaneous procedure. J Am Coll Cardiol. 2012;59(2):113–8.
Vavuranakis M, Kariori M, Voudris V, et al. Predictive factors of vascular complications after transcatheter aortic valve implantation in patients treated with a default percutaneous strategy. Cardiovasc Ther. 2013;31(5):e46–54.
Jernberg T, Attebring MF, Hambraeus K, et al. The Swedish Web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART). Heart. 2010;96(20):1617–21.
Diethrich EB. What do we need to know to achieve durable endoluminal abdominal aortic aneurysm repair? Tex Heart Inst J. 1997;24(3):179–84.
Larzon T, Geijer H, Gruber G, Popek R, Norgren L. Fascia suturing of large access sites after endovascular treatment of aortic aneurysms and dissections. J Endovasc Ther. 2006;13(2):152–7.
Kappetein AP, Head SJ, Genereux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol. 2012;60(15):1438–54.
Mehran R, Rao SV, Bhatt DL, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011;123(23):2736–47.
Cockburn J, de Belder A, Brooks M, et al. Large calibre arterial access device closure for percutaneous aortic valve interventions: use of the Prostar system in 118 cases. Catheter Cardiovasc Interv. 2012;79(1):143–9.
Czerwinska-Jelonkiewicz K, Michalowska I, Witkowski A, et al. Vascular complications after transcatheter aortic valve implantation (TAVI): risk and long-term results. J Thromb Thrombolysis. 2014;37(4):490–8.
Thomas C, Steger V, Heller S, et al. Safety and efficacy of the Prostar XL vascular closing device for percutaneous closure of large arterial access sites. Radiol Res Pract. 2013;2013:875484.
Skagius E, Bosnjak M, Bjorck M, Steuer J, Nyman R, Wanhainen A. Percutaneous closure of large femoral artery access with Prostar XL in thoracic endovascular aortic repair. Eur J Vasc Endovasc Surg. 2013;46(5):558–63.
Nelson PR, Kracjer Z, Kansal N, et al. A multicenter, randomized, controlled trial of totally percutaneous access versus open femoral exposure for endovascular aortic aneurysm repair (the PEVAR trial). J Vasc Surg. 2014;59(5):1181–93.
Vergnat M, Finet G, Rioufol G, Obadia JF. Percutaneous femoral artery access with Prostar device for innovative mitral and aortic interventions. Eur J Cardiothorac Surg. 2011;39(4):600–2.
Hayashida K, Morice MC, Chevalier B, et al. Sex-related differences in clinical presentation and outcome of transcatheter aortic valve implantation for severe aortic stenosis. J Am Coll Cardiol. 2012;59(6):566–71.
Harrison GJ, Thavarajan D, Brennan JA, Vallabhaneni SR, McWilliams RG, Fisher RK. Fascial closure following percutaneous endovascular aneurysm repair. Eur J Vasc Endovasc Surg. 2011;41(3):346–9.
Conflict of interest
The authors have no conflicts of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Barbier, C.E., Lundin, E., Melki, V. et al. Percutaneous Closure in Transfemoral Aortic Valve Implantation: A Single-Centre Experience. Cardiovasc Intervent Radiol 38, 1438–1443 (2015). https://doi.org/10.1007/s00270-015-1117-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-015-1117-0